Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Asahi Kasei Life Science covers a broad range of bioprocess products and services
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
The IND application supports the next phase of development of SBO-154
Pantoprazole Sodium for Injection, 40 mg/vial (Single-Dose Vial) have an estimated market size of US$ 48 million for twelve months ending December 2024 according to IQVIA
According to IQVIA sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, 750 mg/vial, 1.25 g/vial and 1.5 g/vial (Single-dose vial) market achieved annual sales of approximately $39.3 mn
Sensory Boxes include items such as drawing boards and fidget balls to support management of anxiety and improve shopping experience
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
The inspection has concluded with four observations
Subcutaneous pembrolizumab administered every six weeks with a median injection time of two minutes, in combination with chemotherapy, shows consistent results across reported efficacy and safety endpoints compared to IV KEYTRUDA in combination with chemotherapy
Subscribe To Our Newsletter & Stay Updated